Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Filings indexed 662 across all filing types
Latest filing 2022-03-10 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
2021年度董事会审计委员会履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2021年度董事会审计委员会履职情况报告" which translates to the "2021 Annual Board Audit Committee Performance Report." It details the activities and evaluations performed by the audit committee during the year 2021, including oversight of external auditors, internal audit guidance, review of financial reports, and internal control assessments. The document is a report from the audit committee to the board summarizing their work and opinions on audit and control matters for the year. It is not the full annual report (10-K) nor a standalone audit opinion report (AR), but rather a specific audit committee report on their duties and findings. This fits the category of Audit Report / Information (AR) as it focuses on audit committee activities and audit-related oversight without being the full annual report or just a certification. The document length is 3629 characters, which is sufficient for a detailed report but not a brief announcement. Therefore, the best classification is AR with high confidence. FY 2021
2022-03-10 Chinese
2021年度审计报告及财务报表
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告及财务报表" which translates to "Audit Report and Financial Statements" for the fiscal year 2021. It includes detailed audit opinions, key audit matters, and comprehensive financial statements such as consolidated balance sheets, profit and loss statements, cash flow statements, and notes to the financial statements. The presence of an auditor's report with signatures, audit firm details, and extensive financial data confirms this is a standalone audit report rather than a full annual report or a brief announcement. The document length is substantial (15,000 characters), and it contains actual financial data and audit findings, not just a reference or announcement. Therefore, the document fits the category of an Audit Report / Information (AR).
2022-03-10 Chinese
2021年年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public stock issuance by Shenzhen Huitai Medical Device Co., Ltd. It includes specifics on the amount raised, fees paid, net proceeds, usage of funds, management policies, and investment of idle funds. It references regulatory approvals and audit reports related to the fundraising. The document is titled as a "专项报告" (special report) on the storage and actual use of raised funds for the year 2021. It is not an annual report, earnings release, or a general regulatory filing. It specifically focuses on the management and use of capital raised, which aligns with the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed financial data about fundraising and fund usage, not just an announcement or certification, so it is not RPA or RNS. Therefore, the best classification is CAP.
2022-03-10 Chinese
信息披露暂缓与豁免事务管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy and procedural manual titled '信息披露暂缓与豁免事务管理制度' (Information Disclosure Delay and Exemption Management System) for Shenzhen Huitai Medical Devices Co., Ltd. It outlines rules, conditions, internal management, responsibilities, and forms related to delaying or exempting information disclosure under Chinese securities law and Shanghai Stock Exchange regulations. It does not contain financial data, earnings, audit results, or any report of financial performance. Instead, it is a governance and compliance document focused on disclosure management procedures. Therefore, it fits best under Governance Information (CGR). The document length is 4188 characters, which is relatively short but contains substantive policy content rather than a mere announcement or certification, so it is not RPA or RNS. Hence, the classification is CGR with high confidence.
2022-03-10 Chinese
监事会议事规则
Governance Information Classification · 100% confidence The document is titled as the "监事会议事规则" which translates to "Supervisory Board Meeting Rules" for Shenzhen Huitai Medical Equipment Co., Ltd. It details the rules and procedures for the supervisory board meetings, including meeting notices, proposals, voting, responsibilities, and record-keeping. There is no financial data, no report of financial results, no announcement of voting results, no management or board changes, no legal proceedings, no capital updates, and no earnings information. The document is a governance-related internal rules document about the supervisory board's operation and procedures. Therefore, it fits best under Governance Information (CGR). The document length is about 4926 characters, which is sufficient for a detailed governance document, not a brief announcement or notice.
2022-03-10 Chinese
股东大议事规则
Governance Information Classification · 100% confidence The document is titled as the "Shareholders' Meeting Rules" of Shenzhen Huitai Medical Devices Co., Ltd. It extensively details the procedures, rules, and regulations governing the conduct of the company's shareholders' meetings, including the convening, proposal submission, voting, attendance, and execution of resolutions. There is no indication that this document is a report of an actual meeting, nor is it a voting result announcement. Instead, it is a governance document outlining internal rules and procedures related to shareholder meetings. Therefore, it fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2022-03-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.